Assessing Drop Out Rates in Clinical Trials for Diabetes and Anticoagulation
Author Information
Author(s): Heneghan Carl, Perera Rafael, Ward A Alison, Fitzmaurice David, Meats Emma, Glasziou Paul
Primary Institution: Department of Primary Health Care, University of Oxford
Hypothesis
Analyzing dropout rates can provide insights into patient and trial characteristics affecting intervention uptake.
Conclusion
The study introduces relative attrition as a tool to identify factors influencing dropout rates in clinical trials.
Supporting Evidence
- Attrition rates for self-monitoring of blood glucose ranged from 2.3% to 50.0%.
- Self-monitoring of oral anticoagulation showed a significant relative attrition of 6.05.
- High dropout rates were linked to patient characteristics such as age and health status.
- Training and support systems may influence dropout rates in self-monitoring trials.
- Statistical heterogeneity was observed in attrition rates across studies.
Takeaway
This study looks at why people drop out of trials for diabetes and blood-thinning treatments, helping us understand how to keep more people involved.
Methodology
The study analyzed systematic reviews comparing self-monitoring of blood glucose and oral anticoagulation, assessing dropout rates pre- and post-randomization.
Potential Biases
Potential biases due to exclusion of patients and varying quality of included studies.
Limitations
Underreporting of dropout reasons limited the analysis of interaction effects.
Participant Demographics
Participants included adults with type 2 diabetes and those requiring oral anticoagulation, with varying dropout rates.
Statistical Information
P-Value
0.006
Confidence Interval
95% CI, 0.70–2.01 for diabetes; 95% CI, 2.53–14.49 for anticoagulation
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website